Conditions: Sexual Dysfunctions, Psychological
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 949
Healthy volunteers: no

Brief summary:
The objective of this trial is to assess the safety and efficacy of 24-week course of flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally postmenopausal women.

Detailed description:

Arms:
arm 1: flibanserin 100mg po qd arm 2: placebo one tablet po qd

Interventions: intervention 1: flibanserin intervention 2: placebo
Intervention descriptions: intervention 1: patients will be randomized to flibanserin or placebo in a double-blind manner intervention 2: patients will be randomized to flibanserin or placebo in a double-blind manner

Protocol document: